AVXS

AveXis, Inc. Common Stock

$121.47 +$1.94 +1.60%



Shares Bought2
Shares Sold2
Total4
Shares Owned0
Last Price$121.47
Total Return$4.98
Range Today$115.11 - $121.61
52 Week Range$55.10 - $128.00
Open$121.12
Market Cap$3.88B
Volume/Average81.28K/466.67K
P/E Ratio-
Dividend/Yield-




AveXis, Inc. operates as a clinical-stage gene therapy company that engages in the research and development of technology specifically for neurological genetic disease treatment. Its proprietary gene therapy candidate, AVXS-101 has been granted orphan drug designation for the treatment of all types of spinal muscular atrophy and fast track designation for the treatment of spinal muscular atrophy type 1. The company was founded by John D. Harkey, Jr. in 2010 and is headquartered in Chicago, IL.


Wallet Positions

Buy Date Buy Price Quote Return $ Return % Owners

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
17-11-10 19:37 17-12-14 17:02 $94.84 $99.56 +$4.72 +4.98% mistacat
17-11-10 19:35 17-12-01 19:10 $94.79 $95.05 +$0.26 +0.27% funkmasterflexion michrob mistacat